Importantly, RPA1 knockdown potentiated the anti-proliferative effect of oxaliplatin in colon cancer cells, which could be ascribed to inhibition of DNA synthesis evidenced by reduced number of cells in the S phase [37]. The gene discussed is RPA1; the disease is malignant colon neoplasm.